The owners of a clinical research organization operating in 15+ countries of Europe have decided to sell their business. The company presents a strategic opportunity to obtain a strong position in the region and is suitable mainly for larger CRO companies that want to increase or establish a European presence.
The company for sale is a full-service CRO company operating on a multinational scale. Among the players in the industry, the company is known widely for its top-quality and efficient operations with deep CRO and clinical trial expertise. The company has built and retained an impressive roster of long-term clients, including global pharmaceutical and CRO companies with whom it has an outstanding reputation.
The company partners with leading healthcare institutions and has on staff academic and clinical expertise that sets it apart from regional competitors. Currently, more than 200 highly skilled employees are working for this company. The team of the company consists mainly of professionals in pharma, medical or biotech industry.
The operating revenue of the company exceeds 10 million EUR, with a very high, above average EBITDA margin. Both the revenue and margins are growing year to year, further potential for growth exists with a larger strategic partner.
Contact us to get details about this CRO company for sale in Europe
The company is working with top brands from the pharma and biotech industry. The customer portfolio of the seller is very stable and apart from large pharma companies, it includes also clients among midsize and niche pharma players, and non-profits organizations. This diverse and long-tenured client base includes almost 50 companies and this number is growing on an annual basis.
The company is debt-free, profitable and growing. The company has foreign as well as domestic expansion opportunities and wants to increase the turnover from foreign markets.
The owner is looking mainly for a strategically-minded partner with the ability to leverage its key assets and regional knowledge to a dominant position throughout Europe. The executive team in the company is excited about embarking on a new phase of growth.
Please feel free to ask for more information about this clinical research organization in Europe that is currently for sale. If this company does not match your preferences, ask for our other CROs, or other pharmaceutical companies open for a sale. If you are looking for other pharmaceutical businesses for sale, please visit the section pharmaceutical companies for sale. If you are looking to sell your pharmaceutical business or you know about the pharmaceutical company for sale, please visit the section pharmaceutical companies wanted.
Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.